Search

everythinglearnresearchcommunity

for

Search:↓

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Chicken feather gene mutation helps understand human hair disorders.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Increased PPARGC1α relates to hair thinning in common baldness.

Blocking LFA-1 prevents hair loss in mice.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.